Work

Regulation of PPAR-?? target genes by GW501516 in HepG2 cells

Year: 2012
Type: dissertation
Abstract: Peroxisome proliferator-activated receptors (PPARs) are nuclear receptor transcription factors that function as transcription factors regulating expression of various genes. The three isotopes known today are known as PPAR-??, PPAR-?? and PPAR-??. While PPAR-?? and PPAR-?? are involved in regulation of fatty acid ??-oxidation, adipocyte differentiation, and fat storage, PPAR-?? is also rapidly emerging as an important player in lipid metabolism. Recent research shows that PPAR-?? may play a central role in regulation of fatty acid oxidation in skeletal muscle and adipose tissue, and in regulating glucose output in the liver. It is activated by unsaturated or saturated long-chain fatty acids, by prostacyclin, by retinoic acid, and some eicosanoids. Pharmacological PPAR-?? agonist GW501516 has been synthesized and it activates PPAR-?? with a much higher selectivity compared to other PPAR isotypes. Administration of GW501516 has been shown to regulate fatty acid ??-oxidation in skeletal muscle and adipose tissues, and therefore proven to have a significant benefit in improving insulin sensitivity and reducing hyperglycemia in type II diabetes. In addition, PPAR-?? has been implicated in keratinocyte homeostasis and hepatic lipoprotein production. Several genes are relevant to lipid metabolism: ACC2, CPT1 and LPL. The enzyme carnitine palmitoyl transferase, CPTI, plays a major role in regulation of mitochondrial ??-oxidation and catalyzes the transport of long-chain fatty acids from the cytosol into the mitochondrial matrix in preparation for undergoing ??-oxidation. On the other hand, acetyl-CoA carboxylase, ACC2, also regulates the metabolism of fatty acids. When the enzyme is active, the product malonyl-CoA is produced and inhibits the transfer of the fatty acyl group from acyl-CoA and carnitine via CPTI, which inhibits ??-oxidation of fatty acids in the mitochondria. Lipoprotein lipase (LPL) is an enzyme that plays a key role in hydrolyzing triglycerides into free fatty acids in chylomicrons and very low density lipoproteins (VLDL) in order for entry to other tissues. PPAR-?? was activated with GW501516 in HepG2 cells and the gene transcripts and protein expression of ACC2, CPTI and LPL were quantified with end-point PCR, real-time Q-PCR and Western blot. The gene expression of CPTI was also analyzed in rat L6 skeletal muscle cells. It was observed that activation of PPAR-?? with an agonist reduces fatty acid synthesis and enhances genes involved in fatty acid oxidation in the liver. This therefore suggests a switch from a fat-storing pathway to a fat-burning pathway in the liver and a switch of fatty acid oxidation from skeletal muscle cells to liver cells for energy supply.
Language: English
Open Access status: green
OpenAlex ID: W7033693365
Cites: 40
Cited by: 1
Related to: 10